An OptumRx client note viewed by Reuters reveals that new migraine drugs from Amgen (AMGN) and Eli Lilly (LLY) are listed as preferred treatments on its lists of covered drugs, according to Caroline Humer. Teva Pharmaceutical’s (TEVA) rival drug, Aimovig, is excluded on one list from the PBM owned by UnitedHealth (UNH) and patients can pay more for it in some cases on a second list, Reuters added
https://thefly.com/landingPageNews.php?id=2857923
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.